Ultralife (NASDAQ:ULBI – Get Free Report) will issue its quarterly earnings data before the market opens on Thursday, April 25th. Parties interested in participating in the company’s conference call can do so using this link.
Ultralife (NASDAQ:ULBI – Get Free Report) last announced its quarterly earnings data on Thursday, February 15th. The technology company reported $0.18 earnings per share for the quarter. The company had revenue of $44.55 million for the quarter. Ultralife had a return on equity of 7.36% and a net margin of 4.54%.
Ultralife Trading Down 1.5 %
Shares of ULBI stock opened at $8.78 on Thursday. The stock’s fifty day moving average is $9.02 and its two-hundred day moving average is $8.25. The company has a debt-to-equity ratio of 0.19, a quick ratio of 2.02 and a current ratio of 3.80. The firm has a market capitalization of $144.43 million, a P/E ratio of 19.95 and a beta of 1.26. Ultralife has a fifty-two week low of $3.92 and a fifty-two week high of $11.85.
Analyst Ratings Changes
Get Our Latest Stock Report on ULBI
Institutional Inflows and Outflows
Several institutional investors have recently modified their holdings of the stock. Northern Trust Corp raised its holdings in Ultralife by 7.2% in the 2nd quarter. Northern Trust Corp now owns 23,590 shares of the technology company’s stock valued at $114,000 after buying an additional 1,592 shares during the period. State Street Corp raised its holdings in Ultralife by 6.9% in the 1st quarter. State Street Corp now owns 40,120 shares of the technology company’s stock valued at $215,000 after buying an additional 2,596 shares during the period. BlackRock Inc. raised its holdings in Ultralife by 2.0% in the 2nd quarter. BlackRock Inc. now owns 145,230 shares of the technology company’s stock valued at $703,000 after buying an additional 2,873 shares during the period. Citigroup Inc. purchased a new stake in Ultralife in the 3rd quarter valued at about $74,000. Finally, Renaissance Technologies LLC raised its holdings in Ultralife by 5.1% in the 1st quarter. Renaissance Technologies LLC now owns 176,690 shares of the technology company’s stock valued at $710,000 after buying an additional 8,600 shares during the period. Hedge funds and other institutional investors own 30.68% of the company’s stock.
Ultralife Company Profile
Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.
Featured Articles
- Five stocks we like better than Ultralife
- 3 Healthcare Dividend Stocks to Buy
- United Airlines Soars on Earnings Beat
- What is a Stock Market Index and How Do You Use Them?
- J.B. Hunt Hits the Skids: Lower Prices to Come
- How to Invest in Biotech Stocks
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.